GREG ZANTE

CIK 1264949 · Chief Financial Officer · last filed 2026-07-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$7.41M

Companies

3

Total Filings

35

Lifetime Open-Market Net

-$26.48M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VKTX Chief Financial Officer 233,421 $31.74 $7.41M -$26.05M 17 2026-07-29
Viking Therapeutics, Inc. (VKTXW) Delisted Chief Financial Officer 89,751 $4.60 $412.9K $0 2 2021-01-19
SANGAMO THERAPEUTICS, INC (SGMO) Delisted VP, Finance & Administration 0 $0.18 $0 -$430.0K 6 2008-03-12

Recent Filings · Page 2 of 4

35 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-10-28 VKTX Notice (144) −131,687 -$10.28M EDGAR
2024-10-28 VKTX Mixed −37,686 -$9.38M EDGAR
2024-07-31 VKTX Mixed +12,198 -$922.2K EDGAR
2024-07-30 VKTX Notice (144) −16,136 -$922.2K EDGAR
2024-05-03 VKTX Mixed −32,507 -$4.82M EDGAR
2024-05-03 VKTX Notice (144) −66,756 -$4.98M EDGAR
2024-03-27 VKTX Mixed +15,057 -$1.38M EDGAR
2024-03-04 VKTX Mixed +11,574 -$1.71M EDGAR
2024-01-04 VKTX Notice (144) −15,000 -$261.0K EDGAR
2024-01-04 VKTX Mixed +20,340 -$1.38M EDGAR
Showing 1120 of 35
Page 2 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.